#Biotechnology

Reporting, analysis, and useful context collected in one place.

A Single LSD-Derived Dose Shows Phase 3 Promise Against Major Depression

Definium Therapeutics reported that a single dose of DT120 significantly reduced major-depression symptoms six weeks after treatment in a Phase 3 trial. The findings could advance psychedelic medicine toward regulatory review, but full peer-reviewed data, long-term safety and independent confirmation remain essential.

Health•

Daraxonrasib Signals a Potential Turning Point in Pancreatic Cancer

An experimental RAS-targeted therapy more than doubled median overall survival against standard chemotherapy in a closely watched pancreatic-cancer study. Broader confirmation and regulatory review remain necessary.